A. Leigh Corbett

Staff Reporter

Email: corbett@ocbj.com
Phone: 949-833-8373 Extension: 254

Recent Stories

A Love for Plastic Surgery

Niccole Aims to Make People Feel Fabulous

Dr. Michael Niccole is happiest when he does a surgery to improve a person’s looks.

Moms OC’s CEO To CalOptima Board

Pimentel Runs OC’s No. 59 Nonprofit

Chief Executive Pamela Pimentel at Moms Orange County was named to the advisory board of CalOptima, a public health insurance program for low-income individuals.

UCI Study Shows Promise in MS Battle

Stem Cells Used For Nanotech Treatment

UCI researchers said they successfully used a nanotechnology treatment derived from bone marrow stem cells to reverse multiple sclerosis symptoms in mice.

Evolus Says Europe Seeking More Data

Decision Delayed For Europe’s Version of Jeuveau

Newport Beach-based Evolus Inc. (Nasdaq: EOLS) said the European Commission is taking longer than expected to reach a decision on marketing approval for Nuceiva, its European version of the competitor to Allergan’s Botox.

Midday Stock Roundup

The S&P 500 is up 0.4% to 2,890.27 in midday trading.

Tease photo

Applied Innovation Showcases Advances, Entrepreneurs

Event Follows New Beall Family Donation

Elliot Botvinick, Ph.D., a University of California-Irvine professor who is involved in two startups, took home the prize of Entrepreneurial Leader of the Year at UCI’s Applied Innovation’s second annual award ceremony on May 29.

Tease photo

Cryoport’s Hot on Acquisitions

$20.5M Cash Buy of Cryogene

Cryoport Inc. (Nasdaq: CYRX), a provider of cold-chain logistics services for the biopharmaceutical industry, is a hot stock.

Tease photo

Avid Aims for Rebound After CEO Departure

New Analyst Sets $5 Price Target

Tustin-based Avid Bioservices Inc. (Nasdaq: CDMO), a pharmaceutical contract manufacturer that’s seen its share of change the past year, might be returning to the light as its stock gains traction, and the attention of a new analyst.

Tease photo

Midday Stock Report

The S&P 500 rose 0.2% to 2,833.79 in midday trading.

Tease photo

AR Glasses Pass Trial

Eyedaptic Tied to UCI Herbert Institute

Ophthalmology software startup Eyedaptic Inc. in Laguna Beach said it has completed a successful clinical trial for its augmented reality glasses, which are designed to improve quality of life for those suffering from macular degeneration—nearly 150 million people worldwide.

Tease photo

More stories >>